APO Research

APO RESEARCH · REPORT

Nociceptin Receptor

Selected research

Market Analysis & Forecast

Global Nociceptin Receptor Market Analysis and Forecast 2026-2032

Market perspective

The global Nociceptin Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nociceptin Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nociceptin Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nociceptin Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nociceptin Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nociceptin Receptor include Serodus ASA, Orexigen Therapeutics Inc, Grunenthal GmbH, Fuso Pharmaceutical Industries Ltd and Blackthorn Therapeutics Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nociceptin Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nociceptin Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Nociceptin Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nociceptin Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nociceptin Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nociceptin Receptor sales, projected growth trends, production technology, application and end-user industry.

Nociceptin Receptor Segment by Company

Serodus ASA

Orexigen Therapeutics Inc

Grunenthal GmbH

Fuso Pharmaceutical Industries Ltd

Blackthorn Therapeutics Inc

Nociceptin Receptor Segment by Type

GRTTA-2210

GRT-6010

Cebranopadol

BTRX-246040

AT-403

Others

Nociceptin Receptor Segment by Application

Major Depressive Disorder

Drug Addiction

Diabetic Neuropathic Pain

Postherpetic Neuralgia

Others

Nociceptin Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nociceptin Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nociceptin Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nociceptin Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nociceptin Receptor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nociceptin Receptor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nociceptin Receptor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nociceptin Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GRTTA-2210 Major Manufacturers Table 3. GRT-6010 Major Manufacturers Table 4. Cebranopadol Major Manufacturers Table 5. BTRX-246040 Major Manufacturers Table 6. AT-403 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Nociceptin Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Major Depressive Disorder Major Manufacturers Table 10. Drug Addiction Major Manufacturers Table 11. Diabetic Neuropathic Pain Major Manufacturers Table 12. Postherpetic Neuralgia Major Manufacturers Table 13. Others Major Manufacturers Table 14. Nociceptin Receptor Industry Trends Table 15. Nociceptin Receptor Industry Drivers Table 16. Nociceptin Receptor Industry Opportunities and Challenges Table 17. Nociceptin Receptor Industry Restraints Table 18. Global Nociceptin Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Nociceptin Receptor Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Nociceptin Receptor Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Nociceptin Receptor Revenue Market Share by Region (2021-2026) Table 22. Global Nociceptin Receptor Revenue Market Share by Region (2027-2032) Table 23. Global Nociceptin Receptor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global Nociceptin Receptor Sales by Region (2021-2026) & (k units) Table 25. Global Nociceptin Receptor Sales by Region (2027-2032) & (k units) Table 26. Global Nociceptin Receptor Sales Market Share by Region (2021-2026) Table 27. Global Nociceptin Receptor Sales Market Share by Region (2027-2032) Table 28. Global Nociceptin Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Nociceptin Receptor Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Nociceptin Receptor Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Nociceptin Receptor Sales Market Share by Manufacturers (2021-2026) Table 32. Global Nociceptin Receptor Sales Price (US$/unit) of Manufacturers (2021-2026) Table 33. Global Nociceptin Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nociceptin Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Nociceptin Receptor Manufacturers, Product Type & Application Table 36. Global Nociceptin Receptor Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Nociceptin Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nociceptin Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Nociceptin Receptor Revenue Market Share by Type (2021-2026) Table 43. Global Nociceptin Receptor Revenue Market Share by Type (2027-2032) Table 44. Global Nociceptin Receptor Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 46. Global Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 47. Global Nociceptin Receptor Sales Market Share by Type (2021-2026) Table 48. Global Nociceptin Receptor Sales Market Share by Type (2027-2032) Table 49. Global Nociceptin Receptor Price by Type (2021-2026) & (US$/unit) Table 50. Global Nociceptin Receptor Price by Type (2027-2032) & (US$/unit) Table 51. Global Nociceptin Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Nociceptin Receptor Revenue Market Share by Application (2021-2026) Table 55. Global Nociceptin Receptor Revenue Market Share by Application (2027-2032) Table 56. Global Nociceptin Receptor Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 58. Global Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 59. Global Nociceptin Receptor Sales Market Share by Application (2021-2026) Table 60. Global Nociceptin Receptor Sales Market Share by Application (2027-2032) Table 61. Global Nociceptin Receptor Price by Application (2021-2026) & (US$/unit) Table 62. Global Nociceptin Receptor Price by Application (2027-2032) & (US$/unit) Table 63. Serodus ASA Company Information Table 64. Serodus ASA Business Overview Table 65. Serodus ASA Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Serodus ASA Nociceptin Receptor Product Portfolio Table 67. Serodus ASA Recent Development Table 68. Orexigen Therapeutics Inc Company Information Table 69. Orexigen Therapeutics Inc Business Overview Table 70. Orexigen Therapeutics Inc Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio Table 72. Orexigen Therapeutics Inc Recent Development Table 73. Grunenthal GmbH Company Information Table 74. Grunenthal GmbH Business Overview Table 75. Grunenthal GmbH Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Grunenthal GmbH Nociceptin Receptor Product Portfolio Table 77. Grunenthal GmbH Recent Development Table 78. Fuso Pharmaceutical Industries Ltd Company Information Table 79. Fuso Pharmaceutical Industries Ltd Business Overview Table 80. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio Table 82. Fuso Pharmaceutical Industries Ltd Recent Development Table 83. Blackthorn Therapeutics Inc Company Information Table 84. Blackthorn Therapeutics Inc Business Overview Table 85. Blackthorn Therapeutics Inc Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio Table 87. Blackthorn Therapeutics Inc Recent Development Table 88. North America Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 91. North America Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 92. North America Nociceptin Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 93. North America Nociceptin Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 94. North America Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 97. North America Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 98. North America Nociceptin Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 99. North America Nociceptin Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 100. North America Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Nociceptin Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Nociceptin Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 104. North America Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 105. North America Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 106. North America Nociceptin Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 107. North America Nociceptin Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 108. United States Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 109. Canada Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 110. Mexico Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 111. Europe Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 114. Europe Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 115. Europe Nociceptin Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 116. Europe Nociceptin Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 117. Europe Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 120. Europe Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 121. Europe Nociceptin Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 122. Europe Nociceptin Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 123. Europe Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Nociceptin Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Nociceptin Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. Europe Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 128. Europe Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 129. Europe Nociceptin Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 130. Europe Nociceptin Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 131. Germany Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 132. France Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 133. U.K. Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 134. Italy Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 135. Russia Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 136. Spain Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 139. Sweden Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 140. Poland Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 141. China Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 142. China Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 143. China Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 144. China Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 145. China Nociceptin Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 146. China Nociceptin Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 147. China Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 148. China Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 149. China Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 150. China Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 151. China Nociceptin Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 152. China Nociceptin Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 153. Asia Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 156. Asia Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 157. Asia Nociceptin Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 158. Asia Nociceptin Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 159. Asia Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 162. Asia Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 163. Asia Nociceptin Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 164. Asia Nociceptin Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 165. Asia Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Nociceptin Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Nociceptin Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Asia Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 170. Asia Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 171. Asia Nociceptin Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 172. Asia Nociceptin Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 173. Japan Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 174. South Korea Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 175. India Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 176. Australia Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Nociceptin Receptor Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Nociceptin Receptor Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 182. SAMEA Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 183. SAMEA Nociceptin Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 184. SAMEA Nociceptin Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 185. SAMEA Nociceptin Receptor Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Nociceptin Receptor Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 188. SAMEA Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 189. SAMEA Nociceptin Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 190. SAMEA Nociceptin Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 191. SAMEA Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Nociceptin Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Nociceptin Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. SAMEA Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 196. SAMEA Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 197. SAMEA Nociceptin Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 198. SAMEA Nociceptin Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 199. Brazil Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 200. Argentina Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 201. Chile Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 202. Colombia Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 203. Peru Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 205. Israel Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 206. UAE Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 207. Turkey Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 208. Iran Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 209. Egypt Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Nociceptin Receptor Distributors List Table 213. Nociceptin Receptor Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Nociceptin Receptor Image Figure 2. Global Nociceptin Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nociceptin Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. GRTTA-2210 Image Figure 5. GRT-6010 Image Figure 6. Cebranopadol Image Figure 7. BTRX-246040 Image Figure 8. AT-403 Image Figure 9. Others Image Figure 10. Global Nociceptin Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Nociceptin Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 12. Major Depressive Disorder Image Figure 13. Drug Addiction Image Figure 14. Diabetic Neuropathic Pain Image Figure 15. Postherpetic Neuralgia Image Figure 16. Others Image Figure 17. Global Nociceptin Receptor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Nociceptin Receptor Revenue (2021-2032) & (US$ Million) Figure 19. Global Nociceptin Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Nociceptin Receptor Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Nociceptin Receptor Revenue Market Share by Region (2021-2032) Figure 22. Global Nociceptin Receptor Sales (2021-2032) & (k units) Figure 23. Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global Nociceptin Receptor Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Nociceptin Receptor Sales YoY (2021-2032) & (k units) Figure 26. Europe Nociceptin Receptor Sales YoY (2021-2032) & (k units) Figure 27. China Nociceptin Receptor Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) Nociceptin Receptor Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa Nociceptin Receptor Sales YoY (2021-2032) & (k units) Figure 30. Global Nociceptin Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Nociceptin Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Nociceptin Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Nociceptin Receptor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Nociceptin Receptor Revenue Market Share by Type (2021-2032) Figure 36. Global Nociceptin Receptor Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Nociceptin Receptor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Nociceptin Receptor Sales Market Share by Type (2021-2032) Figure 39. Global Nociceptin Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Nociceptin Receptor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Nociceptin Receptor Revenue Market Share by Application (2021-2032) Figure 42. Global Nociceptin Receptor Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global Nociceptin Receptor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Nociceptin Receptor Sales Market Share by Application (2021-2032) Figure 45. North America Nociceptin Receptor Revenue Share by Type (2021-2032) Figure 46. North America Nociceptin Receptor Sales Share by Type (2021-2032) Figure 47. North America Nociceptin Receptor Revenue Share by Application (2021-2032) Figure 48. North America Nociceptin Receptor Sales Share by Application (2021-2032) Figure 49. North America Nociceptin Receptor Revenue Share by Country (2021-2032) Figure 50. North America Nociceptin Receptor Sales Share by Country (2021-2032) Figure 51. Europe Nociceptin Receptor Revenue Share by Type (2021-2032) Figure 52. Europe Nociceptin Receptor Sales Share by Type (2021-2032) Figure 53. Europe Nociceptin Receptor Revenue Share by Application (2021-2032) Figure 54. Europe Nociceptin Receptor Sales Share by Application (2021-2032) Figure 55. Europe Nociceptin Receptor Revenue Share by Country (2021-2032) Figure 56. Europe Nociceptin Receptor Sales Share by Country (2021-2032) Figure 57. China Nociceptin Receptor Revenue Share by Type (2021-2032) Figure 58. China Nociceptin Receptor Sales Share by Type (2021-2032) Figure 59. China Nociceptin Receptor Revenue Share by Application (2021-2032) Figure 60. China Nociceptin Receptor Sales Share by Application (2021-2032) Figure 61. Asia Nociceptin Receptor Revenue Share by Type (2021-2032) Figure 62. Asia Nociceptin Receptor Sales Share by Type (2021-2032) Figure 63. Asia Nociceptin Receptor Revenue Share by Application (2021-2032) Figure 64. Asia Nociceptin Receptor Sales Share by Application (2021-2032) Figure 65. Asia Nociceptin Receptor Revenue Share by Country (2021-2032) Figure 66. Asia Nociceptin Receptor Sales Share by Country (2021-2032) Figure 67. SAMEA Nociceptin Receptor Revenue Share by Type (2021-2032) Figure 68. SAMEA Nociceptin Receptor Sales Share by Type (2021-2032) Figure 69. SAMEA Nociceptin Receptor Revenue Share by Application (2021-2032) Figure 70. SAMEA Nociceptin Receptor Sales Share by Application (2021-2032) Figure 71. SAMEA Nociceptin Receptor Revenue Share by Country (2021-2032) Figure 72. SAMEA Nociceptin Receptor Sales Share by Country (2021-2032) Figure 73. Nociceptin Receptor Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Nociceptin Receptor Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • GRTTA-2210
  • GRT-6010
  • Cebranopadol
  • BTRX-246040
  • AT-403
  • Others
Applications
  • Major Depressive Disorder
  • Drug Addiction
  • Diabetic Neuropathic Pain
  • Postherpetic Neuralgia
  • Others
Companies covered
  • Serodus ASA
  • Orexigen Therapeutics Inc
  • Grunenthal GmbH
  • Fuso Pharmaceutical Industries Ltd
  • Blackthorn Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nociceptin Receptor Market by Type
  3. 1.2.1 Global Nociceptin Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GRTTA-2210
  5. 1.2.3 GRT-6010
  6. 1.2.4 Cebranopadol
  7. 1.2.5 BTRX-246040
  8. 1.2.6 AT-403
  9. 1.2.7 Others
  10. 1.3 Nociceptin Receptor Market by Application
  11. 1.3.1 Global Nociceptin Receptor Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Major Depressive Disorder
  13. 1.3.3 Drug Addiction
  14. 1.3.4 Diabetic Neuropathic Pain
  15. 1.3.5 Postherpetic Neuralgia
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Nociceptin Receptor Market Dynamics
  1. 2.1 Nociceptin Receptor Industry Trends
  2. 2.2 Nociceptin Receptor Industry Drivers
  3. 2.3 Nociceptin Receptor Industry Opportunities and Challenges
  4. 2.4 Nociceptin Receptor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nociceptin Receptor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nociceptin Receptor Revenue by Region
  3. 3.2.1 Global Nociceptin Receptor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nociceptin Receptor Revenue by Region (2021-2026)
  5. 3.2.3 Global Nociceptin Receptor Revenue by Region (2027-2032)
  6. 3.2.4 Global Nociceptin Receptor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nociceptin Receptor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nociceptin Receptor Sales by Region
  9. 3.4.1 Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nociceptin Receptor Sales by Region (2021-2026)
  11. 3.4.3 Global Nociceptin Receptor Sales by Region (2027-2032)
  12. 3.4.4 Global Nociceptin Receptor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nociceptin Receptor Revenue by Manufacturers
  2. 4.1.1 Global Nociceptin Receptor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nociceptin Receptor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nociceptin Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nociceptin Receptor Sales by Manufacturers
  6. 4.2.1 Global Nociceptin Receptor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nociceptin Receptor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nociceptin Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nociceptin Receptor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nociceptin Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nociceptin Receptor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nociceptin Receptor Manufacturers, Product Type & Application
  13. 4.7 Global Nociceptin Receptor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nociceptin Receptor Market CR5 and HHI
  16. 4.8.2 2025 Nociceptin Receptor Tier 1, Tier 2, and Tier 3
5 Nociceptin Receptor Market by Type
  1. 5.1 Global Nociceptin Receptor Revenue by Type
  2. 5.1.1 Global Nociceptin Receptor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nociceptin Receptor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nociceptin Receptor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nociceptin Receptor Sales by Type
  6. 5.2.1 Global Nociceptin Receptor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nociceptin Receptor Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Nociceptin Receptor Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nociceptin Receptor Price by Type
6 Nociceptin Receptor Market by Application
  1. 6.1 Global Nociceptin Receptor Revenue by Application
  2. 6.1.1 Global Nociceptin Receptor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nociceptin Receptor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nociceptin Receptor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nociceptin Receptor Sales by Application
  6. 6.2.1 Global Nociceptin Receptor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nociceptin Receptor Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Nociceptin Receptor Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nociceptin Receptor Price by Application
7 Company Profiles
  1. 7.1 Serodus ASA
  2. 7.1.1 Serodus ASA Company Information
  3. 7.1.2 Serodus ASA Business Overview
  4. 7.1.3 Serodus ASA Nociceptin Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Serodus ASA Nociceptin Receptor Product Portfolio
  6. 7.1.5 Serodus ASA Recent Developments
  7. 7.2 Orexigen Therapeutics Inc
  8. 7.2.1 Orexigen Therapeutics Inc Company Information
  9. 7.2.2 Orexigen Therapeutics Inc Business Overview
  10. 7.2.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio
  12. 7.2.5 Orexigen Therapeutics Inc Recent Developments
  13. 7.3 Grunenthal GmbH
  14. 7.3.1 Grunenthal GmbH Company Information
  15. 7.3.2 Grunenthal GmbH Business Overview
  16. 7.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grunenthal GmbH Nociceptin Receptor Product Portfolio
  18. 7.3.5 Grunenthal GmbH Recent Developments
  19. 7.4 Fuso Pharmaceutical Industries Ltd
  20. 7.4.1 Fuso Pharmaceutical Industries Ltd Company Information
  21. 7.4.2 Fuso Pharmaceutical Industries Ltd Business Overview
  22. 7.4.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio
  24. 7.4.5 Fuso Pharmaceutical Industries Ltd Recent Developments
  25. 7.5 Blackthorn Therapeutics Inc
  26. 7.5.1 Blackthorn Therapeutics Inc Company Information
  27. 7.5.2 Blackthorn Therapeutics Inc Business Overview
  28. 7.5.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio
  30. 7.5.5 Blackthorn Therapeutics Inc Recent Developments
8 North America
  1. 8.1 North America Nociceptin Receptor Market Size by Type
  2. 8.1.1 North America Nociceptin Receptor Revenue by Type (2021-2032)
  3. 8.1.2 North America Nociceptin Receptor Sales by Type (2021-2032)
  4. 8.1.3 North America Nociceptin Receptor Price by Type (2021-2032)
  5. 8.2 North America Nociceptin Receptor Market Size by Application
  6. 8.2.1 North America Nociceptin Receptor Revenue by Application (2021-2032)
  7. 8.2.2 North America Nociceptin Receptor Sales by Application (2021-2032)
  8. 8.2.3 North America Nociceptin Receptor Price by Application (2021-2032)
  9. 8.3 North America Nociceptin Receptor Market Size by Country
  10. 8.3.1 North America Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nociceptin Receptor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nociceptin Receptor Market Size by Type
  2. 9.1.1 Europe Nociceptin Receptor Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nociceptin Receptor Sales by Type (2021-2032)
  4. 9.1.3 Europe Nociceptin Receptor Price by Type (2021-2032)
  5. 9.2 Europe Nociceptin Receptor Market Size by Application
  6. 9.2.1 Europe Nociceptin Receptor Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nociceptin Receptor Sales by Application (2021-2032)
  8. 9.2.3 Europe Nociceptin Receptor Price by Application (2021-2032)
  9. 9.3 Europe Nociceptin Receptor Market Size by Country
  10. 9.3.1 Europe Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nociceptin Receptor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nociceptin Receptor Market Size by Type
  2. 10.1.1 China Nociceptin Receptor Revenue by Type (2021-2032)
  3. 10.1.2 China Nociceptin Receptor Sales by Type (2021-2032)
  4. 10.1.3 China Nociceptin Receptor Price by Type (2021-2032)
  5. 10.2 China Nociceptin Receptor Market Size by Application
  6. 10.2.1 China Nociceptin Receptor Revenue by Application (2021-2032)
  7. 10.2.2 China Nociceptin Receptor Sales by Application (2021-2032)
  8. 10.2.3 China Nociceptin Receptor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nociceptin Receptor Market Size by Type
  2. 11.1.1 Asia Nociceptin Receptor Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nociceptin Receptor Sales by Type (2021-2032)
  4. 11.1.3 Asia Nociceptin Receptor Price by Type (2021-2032)
  5. 11.2 Asia Nociceptin Receptor Market Size by Application
  6. 11.2.1 Asia Nociceptin Receptor Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nociceptin Receptor Sales by Application (2021-2032)
  8. 11.2.3 Asia Nociceptin Receptor Price by Application (2021-2032)
  9. 11.3 Asia Nociceptin Receptor Market Size by Country
  10. 11.3.1 Asia Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nociceptin Receptor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nociceptin Receptor Market Size by Type
  2. 12.1.1 SAMEA Nociceptin Receptor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nociceptin Receptor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nociceptin Receptor Price by Type (2021-2032)
  5. 12.2 SAMEA Nociceptin Receptor Market Size by Application
  6. 12.2.1 SAMEA Nociceptin Receptor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nociceptin Receptor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nociceptin Receptor Price by Application (2021-2032)
  9. 12.3 SAMEA Nociceptin Receptor Market Size by Country
  10. 12.3.1 SAMEA Nociceptin Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nociceptin Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nociceptin Receptor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nociceptin Receptor Value Chain Analysis
  2. 13.1.1 Nociceptin Receptor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nociceptin Receptor Production Mode & Process
  6. 13.2 Nociceptin Receptor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nociceptin Receptor Distributors
  9. 13.2.3 Nociceptin Receptor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research